The World Health Organization (WHO) said it would look at whether the international drug patent system prevents developing countries from obtaining needed medicines, vaccines and diagnostic tests. The 192 WHO members agreed at an annual meeting in Geneva to launch an intergovernmental group to look for gaps in medical research and development, and draw up […]
The Boston Globe recently ran an article that nanotechnology is about to be the next big thing in bioscience. Although nanotechnology has had a lot of ups and downs in its enthusiam in the marketplace, it’s still remains mostly a laboratory study subject. Now, nanotech seems staged to make huge leaps in medical treatment, so […]
The Human Genome Project, started in started in 1990 to identify genes, has finally come to a close with the publication of the last chromosome sequence in the Human Genome, chromosome 1. It took 150 scientists 10 years to complete the sequence of chromosome 1, which contains nearly twice as many genes as the average […]
[Today’s post is a guest commentary on the NewStandard article about drug companies getting taxpayer supported government grants and then extracting large profits on drug sales.] If I may comment on the [previous post: Do Drug Companies ‘Gouge’ Consumers With Taxpayer Handouts? ], what is the fair price for any product? When people purchase high-priced […]
The NewStandard ran an article outlining that Drug Firms ‘gouge’ consumers by taking taxpayer handouts. The article points to the government grants offered to Big Pharma companies, which then make huge profits off the drugs they sell. Hence, the argument goes, we are paying twice for drugs. If only it were that simple. American consumers […]
The Midwest will be showing its strengths, especially in the areas of agricultural biotech and in the convergence of the medical device, diagnostic and therapeutic companies, at the upcoming BIO 2006 in Chicago next week. I will be among the predicted record attendance of over 25,000 registrants. If you’d like to take time to meet […]
Well, I’m back from my hiatus now that the Google-Patent Baristas acquisition has fallen apart (they don’t even serve decent coffee). The WiredGC posted its own brand of foolery in an article about Large Firm Associates wanting to form a union to enforce wage and labor rules. Associates are upset over massive salary increases and […]
By April Balatro Staff Writer Saturday, April 1, 2006 Google Inc. (NASDAQ:GOOG) announced it has agreed to acquire Patent Baristas, an intellectual property law blog for the biotechnology and pharmaceutical industries, for $1.3 billion in stock and other consideration. Patent Baristas offers innovative intellectual property blogging that connects millions of people around the world with […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
